IRIS
Amati, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.295
AS - Asia 1.587
EU - Europa 586
SA - Sud America 232
Continente sconosciuto - Info sul continente non disponibili 84
AF - Africa 38
OC - Oceania 11
Totale 4.833
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.208
SG - Singapore 878
CN - Cina 361
BR - Brasile 193
IT - Italia 162
VN - Vietnam 130
FI - Finlandia 87
IE - Irlanda 64
GB - Regno Unito 63
DE - Germania 62
IN - India 49
CA - Canada 43
HK - Hong Kong 42
SE - Svezia 33
BD - Bangladesh 27
RU - Federazione Russa 26
FR - Francia 23
MX - Messico 19
AR - Argentina 16
ES - Italia 15
IQ - Iraq 13
TR - Turchia 12
PL - Polonia 11
AU - Australia 9
JP - Giappone 9
MY - Malesia 9
PK - Pakistan 9
CR - Costa Rica 7
ID - Indonesia 7
ZA - Sudafrica 7
NL - Olanda 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
LT - Lituania 5
MA - Marocco 5
PE - Perù 5
UA - Ucraina 5
VE - Venezuela 5
AO - Angola 4
CO - Colombia 4
DZ - Algeria 4
EC - Ecuador 4
JM - Giamaica 4
NG - Nigeria 4
PH - Filippine 4
EE - Estonia 3
HN - Honduras 3
LV - Lettonia 3
NI - Nicaragua 3
PT - Portogallo 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CL - Cile 2
EG - Egitto 2
GR - Grecia 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
QA - Qatar 2
RO - Romania 2
SV - El Salvador 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AT - Austria 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
BY - Bielorussia 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
KR - Corea 1
KW - Kuwait 1
LI - Liechtenstein 1
LU - Lussemburgo 1
MN - Mongolia 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
UY - Uruguay 1
Totale 4.749
Salva come PNG Salva come JPEG
Città #
Singapore 377
San Jose 320
Ashburn 277
Shanghai 158
The Dalles 130
New York 110
Boardman 108
Beijing 91
Council Bluffs 87
Helsinki 86
Dallas 80
Los Angeles 76
Dublin 62
Santa Clara 54
Ho Chi Minh City 41
Milan 36
Hong Kong 34
Phoenix 30
Hanoi 24
London 24
Naples 23
Princeton 22
Chicago 21
Falkenstein 21
Moscow 19
Buffalo 18
Pune 17
São Paulo 17
Abbeville 16
Assago 16
Chennai 16
Chandler 14
Orem 12
Seattle 12
Boston 11
Da Nang 11
Warsaw 11
Atlanta 10
Brooklyn 10
Charlotte 10
Montreal 10
Denver 9
Miami 9
Toronto 9
Mexico City 8
Shijiazhuang 8
Frankfurt am Main 7
Houston 7
San Francisco 7
Stockholm 7
Ankara 6
Chiang Mai 6
Dhaka 6
Philadelphia 6
Rio de Janeiro 6
Baghdad 5
Casal di Principe 5
Johannesburg 5
Kuala Lumpur 5
Manchester 5
Milwaukee 5
Pasadena 5
Queens 5
San José 5
Valencia 5
Wanchai 5
Benin City 4
Cleveland 4
Guangzhou 4
Hangzhou 4
Kansas City 4
Lima 4
Mumbai 4
Nairobi 4
Pittsburgh 4
Quận Ba 4
Santo André 4
Southwark 4
Sydney 4
Amsterdam 3
Belo Horizonte 3
Berlin 3
Birmingham 3
Bologna 3
Cagliari 3
Campinas 3
Cincinnati 3
Columbus 3
Dolianova 3
Florence 3
Goiânia 3
Guildford 3
Haiphong 3
Hillsboro 3
Hải Dương 3
Las Vegas 3
Lawrence 3
Luanda 3
Managua 3
Melbourne 3
Totale 2.793
Salva come PNG Salva come JPEG
Nome #
Diagnosis and management of patients with alpha 1-antitrypsin deficiency: an Italian perspective 140
COVID-19 in Immunocompromised Patients: A Systematic Review 120
Cardiovascular Complications in Community-Acquired Pneumonia 113
Treatable traits in interstitial lung diseases: a call to action 106
Community-acquired pneumonia 105
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 95
Diagnosis and Initial Investigation of Bronchiectasis 89
COVID-19 in lung transplant recipients: A case series from Milan, Italy 86
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 85
COVID-19 Network: the response of an Italian Reference Institute to research challenges about a new pandemia 81
Innate and Adaptive Lymphocytes in Non-Tuberculous Mycobacteria Lung Disease: A Review 80
COVID-19 multidisciplinary high dependency unit: the Milan model 80
An extensive bundle of tests is needed to detect treatable causes of bronchiectasis (Bx) 80
Microbial Dysregulation of the Gut-Lung Axis in Bronchiectasis 78
Onset of systemic arterial hypertension after initiation of elexacaftor/tezacaftor/ivacaftor in adults with cystic fibrosis: A case series 77
Post-COVID-19 sequelae 77
SARS-CoV-2 vaccines: A critical perspective through efficacy data and barriers to herd immunity 77
Cardiovascular side-effects of common antibiotics 76
Overweight and obesity in adults with cystic fibrosis: An Italian multicenter cohort study 75
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 75
What is the best technique to extract bacterial DNA from sputum? 75
Comparison of different conditions for DNA extraction in sputum - a pilot study 74
Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia 74
Prognostic parameters of in-hospital mortality in COVID-19 patients-An Italian experience 74
Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia 74
Aspiration risks factors, microbiology and empiric antibiotics for patients hospitalized with community-acquired pneumonia 74
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 72
Switching to nebulised short acting bronchodilators does not increase the risk of arrhythmia in patients hospitalized with a COPD exacerbation 72
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes 71
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 71
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 70
How to Identify Causes and Predisposing Factors in Bronchiectasis 69
Protease-Antiprotease Imbalance in Bronchiectasis 69
Dysregulation of the microbial ‘gut-lung’ axis in bronchiectasis 69
Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients 69
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders 68
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 68
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience 67
Site of care and multidisciplinary approach 66
Antibiotics for lung disease and cancer 66
T2-High Endotype and Response to Biological Treatments in Patients with Bronchiectasis 66
First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases 66
Neutrophil elastase in bronchiectasis 65
Walking the path of treatable traits in interstitial lung diseases 64
Respiratory failure in COVID-19: a patient's perspective and clinical cases 64
Emerging Resistance of Gram Negative Pathogens in Community-Acquired Pneumonia 63
Phenotyping in bronchiectasis: are we moving toward a personalized medicine? 62
Treatable Traits in Systemic Sclerosis 61
Investigating the Etiology of Bronchiectasis: You Do Not Find What You Do Not Look For 60
Thrombocytosis during Stable State Predicts Mortality in Bronchiectasis 60
Glucocorticoid Therapy in COVID-19 59
When and how ruling out cystic fibrosis in adult patients with bronchiectasis 58
The biology of pulmonary exacerbations in bronchiectasis 58
Diagnostic delay in bronchiectasis: an Italian perspective 56
Respiratory viruses in stable bronchiectasis: A multicenter evaluation in Northern Italy 54
Risk factors and guideline adherence of empiric antibiotic use in community-acquired pneumonia 54
One Size Does Not Fit All: Moving Towards a Personalized Approach for Steroids in COVID-19 52
Heterogeneity of weight gain after initiation of Elexacaftor/Tezacaftor/Ivacaftor in people with cystic fibrosis 51
Prognostic value of copeptin and mid-regional proadrenomedullin in COVID-19-hospitalized patients 50
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis 50
Microbial Inflammatory Networks in Bronchiectasis Exacerbators With Pseudomonas aeruginosa 49
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review 49
Lung Recruitability of COVID-19 Pneumonia in Patients Undergoing Helmet CPAP 48
Clinical profile and in-hospital outcomes of patients hospitalised for bronchiectasis exacerbation 45
Response to: are there over 200 distinct types of interstitial lung diseases? 45
Predictors of Helmet CPAP Failure in COVID-19 Pneumonia: A Prospective, Multicenter, and Observational Cohort Study 45
Relationship Between Lung Volumes and Heterogeneity in the Response to Elexacaftor/Tezacaftor/Ivacaftor in Patients With Cystic Fibrosis and Advanced Lung Disease 44
Treatable traits and challenges in the clinical management of non-tuberculous mycobacteria lung disease in people with cystic fibrosis 42
Global Variation in Pneumonia Epidemiology 26
Bronchiectasis in Italy: an analysis of the EMBARC registry 24
Home-based rehabilitation in interstitial lung disease: picturing the present and drawing the future through a systematic review of the literature 19
Accuracy, comprehensiveness and understandability of AI-generated answers to questions from people with COPD: the AIR-COPD Study 17
Totale 4.833
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.744
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202211 0 0 0 0 0 0 0 0 2 3 4 2
2022/2023225 4 3 3 5 6 0 63 8 32 63 27 11
2023/2024715 53 64 122 67 32 107 68 31 9 45 50 67
2024/2025906 15 7 17 24 32 105 55 35 204 209 93 110
2025/20262.112 322 130 74 114 130 116 623 95 133 146 80 149
2026/2027864 68 143 524 129 0 0 0 0 0 0 0 0
Totale 4.833